Jazz Pharmaceuticals plc (JAZZ) financial statements (2020 and earlier)

Company profile

Business Address FIFTH FLOOR, WATERLOO EXCHANGE
DUBLIN, 4
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments637310386426989684637
Cash and cash equivalents637310386366989684637
Short-term investments   60   
Receivables356264224234210186125
Inventory, net of allowances, customer advances and progress billings79534334193029
Inventory79534334193029
Prepaid expense3925232521137
Deferred costs     3315
Disposal group, including discontinued operation     33 
Deferred tax assets    4834
Other current assets79687729192134
Other undisclosed current assets440515215  (33)(15)
Total current assets:1,6301,2349687481,2581,016865
Noncurrent Assets
Operating lease, right-of-use asset139
Property, plant and equipment132200170107865814
Intangible assets, net (including goodwill)3,3613,6593,9273,9061,8432,1401,263
Goodwill920928948894657703450
Intangible assets, net (excluding goodwill)2,4412,7312,9793,0121,1861,437812
Deferred income tax assets221
Other noncurrent assets4843161428167
Other undisclosed noncurrent assets767422514610989
Total noncurrent assets:3,9093,9694,1554,0522,1022,3231,374
TOTAL ASSETS:5,5395,2035,1244,8003,3603,3392,238
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities326307245220188243141
Accounts payable48412422222521
Accrued liabilities268265199193164164120
Employee-related liabilities     46 
Taxes payable111225280
Deferred revenue5
Debt333341363896
Deferred revenue and credits91111
Deferred tax liabilities    96
Contract with customer, liability5
Other undisclosed current liabilities     (46)50
Total current liabilities:364345294257227217204
Noncurrent Liabilities
Long-term debt and lease obligation1,7251,5631,5401,9941,1671,333544
Long-term debt, excluding current maturities1,5741,5631,5401,9941,1671,333544
Operating lease, liability151
Liabilities, other than long-term debt338228193672367418194
Deferred revenue and credits163446
Deferred revenue5
Contract with customer, liability10
Deferred tax liabilities, net  557294375168
Deferred income tax liabilities224
Other liabilities109219177113693820
Other undisclosed noncurrent liabilities 309383    
Total noncurrent liabilities:2,0632,1012,1172,6651,5341,751739
Total liabilities:2,4282,4462,4112,9231,7611,968943
Stockholders' equity
Stockholders' equity attributable to parent, including:3,1112,7572,7131,8771,5991,3711,296
Common stock0000000
Additional paid in capital2,2662,1141,9351,6651,5631,4581,220
Accumulated other comprehensive income (loss)(223)(198)(141)(317)(267)(122)56
Retained earnings1,0688419185293033519
Other undisclosed stockholders' equity attributable to parent111 111
Stockholders' equity attributable to noncontrolling interest     0 
Other undisclosed stockholders' equity   1   
Total stockholders' equity:3,1112,7572,7131,8771,5991,3711,296
TOTAL LIABILITIES AND EQUITY:5,5395,2035,1244,8003,3603,3392,238

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues2,1621,8911,6191,4881,3251,173872
Revenue, net1,6011,4771,3171,163865
Cost of revenue(238)      
Gross profit:1,9241,8911,6191,4881,3251,173872
Operating expenses(1,392)(1,276)(1,090)(896)(817)(977)(532)
Operating income:532615529592508196340
Nonoperating income (expense)(6)(7)(10)319(2)
Foreign currency transaction gain (loss), before tax(6)(7)(10)3   
Other nonoperating income (expense)    19(2)
Interest and debt expense(59)(57)(38)   (5)
Other undisclosed loss from continuing operations before equity method investments, income taxes(13)(22)(40)(63)(74)(53)(26)
Income from continuing operations before equity method investments, income taxes:454529441532436152308
Loss from equity method investments(4)(2)(1)(0)   
Income from continuing operations before income taxes:450527440532436152308
Income tax expense (benefit)73(80)48(135)(106)(94)(92)
Net income:52344748839733057216
Net income attributable to noncontrolling interest    01 
Net income available to common stockholders, diluted:52344748839733058216

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:52344748839733057216
Other comprehensive income (loss)(26)(57)176(50)(145)(178)25
Comprehensive income (loss):498390664347184(121)241
Comprehensive income, net of tax, attributable to noncontrolling interest    01 
Comprehensive income (loss), net of tax, attributable to parent:498390664347184(120)241

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: